Frank Mceachern

Biography

Frank has nearly a decade of executive leadership experience in the implantable neurostimulation field. As the executive chairman and CEO of MicroTransponder, McEachern has led the financing efforts to raise over $22 Million in equity financing and over $9 Million in non-dilutive financing for the Company. He has implemented a sophisticated international IP and licensing strategy and developed an international reimbursement strategy for each of the Company’s products. He has hired and led a top class team of scientists, engineers, clinical, and regulatory personnel through the development of multiple implantable stimulation systems through to sales. This process included several large scale U.S. and international clinical trials. Prior to joining MicroTransponder, He  worked as a corporate securities attorney at Baker Botts where he represented Advanced Neuromodulation Systems (ANS) in the merger of ANS with St. Jude Medical, the largest neurostimulation merger to date. McEachern also serves on the Board of the University of Texas Biomedical Device Center. He received his BBA from the University of Texas Business Honors Program and completed his JD at the University of Texas at Austin.

Research Interest

Neuromodulation Systems, Advanced Neuromodulation Systems, biomedical